Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apellis Pharmaceuticals (APLS) Asset Utilization Ratio (2020 - 2025)

Apellis Pharmaceuticals filings provide 6 years of Asset Utilization Ratio readings, the most recent being 0.94 for Q4 2025.

  • For the quarter ending Q4 2025, Asset Utilization Ratio rose 7.57% year-over-year to 0.94, compared with a TTM value of 0.94 through Dec 2025, up 7.57%, and an annual FY2025 reading of 1.02, up 9.69% over the prior year.
  • Asset Utilization Ratio hit 0.94 in Q4 2025 for Apellis Pharmaceuticals, down from 1.08 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 1.08 in Q3 2025, with the low at 0.08 in Q1 2022.
  • Median Asset Utilization Ratio over the past 5 years was 0.38 (2021), compared with a mean of 0.48.
  • The sharpest move saw Asset Utilization Ratio tumbled 72.97% in 2022, then surged 434.39% in 2023.
  • Year by year, Asset Utilization Ratio stood at 0.09 in 2021, then dropped by 2.35% to 0.09 in 2022, then skyrocketed by 434.39% to 0.49 in 2023, then skyrocketed by 77.18% to 0.87 in 2024, then increased by 7.57% to 0.94 in 2025.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.94, 1.08, and 0.93 for Q4 2025, Q3 2025, and Q2 2025 respectively.